Press release
PREMIER Biosoft International releases SimLipid with support for structural elucidation.
SimLipid - Innovative Lipid Characterization Software
SimLipid profiles lipids by matching the experimental MS spectra with its own comprehensive, robust and annotated database, consisting of 8 lipid categories and 21905 lipid species. SimLipid enables users to perform MS/MS data analysis of Glycerophospholipids, Glycerolipids, Prenol Lipids and Saccharolipids with ease. The resulting structures are plotted in 2D layout and sorted based on an innovating ranking algorithm that maps the degree of proximity of theoretical lipids with experimental data. High Resolution Accurate Mass (HRAM) data with error tolerance between 1-20 ppm can also be analyzed, improving the accuracy of prediction.
SimLipid provides a high throughput module to streamline isotope percentage calculations for MS lipid profiles and correct the experimental peak intensities to remove lipids with isotopic overlaps, assisting in accurate quatitation of lipids from biological mixtures.
“The advancement in lipidomics has largely been inhibited by the lack of analysis tools. We developed SimLipid for systems-level analysis of lipids, placing a powerful tool in the hands of researchers working in the area of biomedical research in general, and drug and biomarker development in particular.” said Kay Brown, V.P. Business Development and Marketing.
For details, please visit: http://www.premierbiosoft.com/lipid/index.html
Founded in 1994, is a group of computer scientists and biologists dedicated to producing cutting edge intuitive software for research in life sciences. Our goal is to study the most recent innovations in life sciences and translate them into software products to aid research.
More information is available at http://www.PremierBiosoft.com.
Contact:
Arun Apte
PREMIER Biosoft International
650-856-2703
http://www.PremierBiosoft.com
Email: support@premierbiosoft.com
PREMIER Biosoft International
3786 Corina Way
Palo Alto CA 94303-4504
USA
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PREMIER Biosoft International releases SimLipid with support for structural elucidation. here
News-ID: 168473 • Views: …
More Releases for Lipid
Key Trends Shaping the Future Lipid Market From 2025-2034: Advancements In Scala …
What industry-specific factors are fueling the growth of the lipid market?
The lipid market's expansion is projected to be fuelled by a growing demand for nutritional supplements. The increase in nutritional requirements resulting from a more active lifestyle or health condition is often met with supplementation. Lipid-based nutrient supplements - those where lipids supply the majority of the energy and also encompass protein, energy, essential fatty acids, and micronutrients - play…
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
Lipid Regulators Market Report 2024 - Lipid Regulators Market Trends And Growth
"The Business Research Company recently released a comprehensive report on the Global Lipid Regulators Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Lipid Research: Creative Biolabs Launches Its Lipid-Based Delivery Solutions
Creative Biolabs, a leading biotechnology company, unveiled its latest solutions for developing lipid-based delivery systems last week.
New York, USA - April 18, 2024 - "Liposomes as excellent drug delivery vehicles continuously drive innovation in drug delivery development and open up new breakthroughs and possibilities. Building on this momentum, we have designed a suite of solutions for lipid-based delivery system development," said an expert from the Lipid Research Department, Creative Biolabs.
Image:…
Creative Biolabs: Unlocking Lipid Biology With Complete Lipid Analysis Solutions
Creative Biolabs, a pioneer in the field of biotechnology, is delighted to announce the launch of cutting-edge assay and analysis solutions tailored specifically for liposome drug delivery.
New York, USA - March 26, 2024 - Liposomes, versatile lipid-based structures, have emerged as promising carriers for drug delivery due to their biocompatibility, flexibility, and capacity to encapsulate a wide range of therapeutics. To ensure the successful development of lipid-based drug delivery systems,…
Lipid Nanoparticles (LNP) Market Growth Is Attributed To The Increasing Demand F …
According to Precision Business Insights (PBI) latest report, the Lipid Nanoparticles (LNP) Market size is expected to be worth USD 675.0 Million in 2022, growing at a 7.5% CAGR from 2022 to 2028. The growing demand for therapeutic drugs and vaccinations to combat viral illnesses like Ebola, influenza, HIV, and other viruses, together with the traditional vaccine approach's failure to find vaccines in time for a crisis, are all contributing…
